Patents by Inventor Jon Voutila

Jon Voutila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HNF4a saRNA compositions and methods of use
    Patent number: 11965163
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: September 28, 2021
    Date of Patent: April 23, 2024
    Assignee: MiNA Therapeutics Limited
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • HNF4A SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20240035026
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: September 28, 2021
    Publication date: February 1, 2024
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • Stabilized saRNA Compositions and Methods of Use
    Publication number: 20240018519
    Abstract: The invention relates to modified oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: April 12, 2023
    Publication date: January 18, 2024
    Applicant: MiNA Therapeutics Limited
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • STABILIZED HNF4A SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20230031703
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: August 10, 2022
    Publication date: February 2, 2023
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • Stabilized HNF4A saRNA compositions and methods of use
    Patent number: 11447773
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: September 20, 2022
    Assignee: MINA THERAPEUTICS LIMITED
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • OLIGONUCLEOTIDE CONJUGATE COMPOSITIONS AND METHODS OF USE
    Publication number: 20220281911
    Abstract: The disclosure relates to GalNAc moieties comprising at least one GalNAc monomer. The disclosure also relates to GalNAc-oligonucleotide conjugates comprising GalNAc moieties and oligonucleotides, e.g., saRNAs or siRNAs useful in regulating the expression of a target gene. Methods of using the GalNAc-oligonucleotide conjugates are also provided.
    Type: Application
    Filed: August 19, 2020
    Publication date: September 8, 2022
    Inventors: Alexandre Debacker, Jon Voutila, Lee Mitchell, Catherine M. McKeen
  • HNF4A SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20220090074
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: September 28, 2021
    Publication date: March 24, 2022
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • HNF4A saRNA compositions and methods of use
    Patent number: 11162099
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: November 2, 2021
    Assignee: MINA THERAPEUTICS LIMITED
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • STABILIZED HNF4A SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200255827
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 13, 2020
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye
  • HNF4A SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200255826
    Abstract: The invention relates to saRNA targeting an HNF4a transcript and therapeutic compositions comprising said saRNA. Methods of using the therapeutic compositions are also provided.
    Type: Application
    Filed: September 7, 2018
    Publication date: August 13, 2020
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Monika Krampert, Markus Hossbach
  • STABILIZED SARNA COMPOSITIONS AND METHODS OF USE
    Publication number: 20200208152
    Abstract: The invention relates to modified oligonucleotides, e.g., saRNAs useful in upregulating the expression of a target gene and therapeutic compositions comprising such oligonucleotides. Methods of using the oligonucleotides and the therapeutic compositions are also provided.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 2, 2020
    Inventors: Hans E. Huber, David Blakey, Jon Voutila, Vikash Reebye